Name: UMIN ID:
Unique ID issued by UMIN | UMIN000022386 |
---|---|
Receipt number | R000025799 |
Scientific Title | AVASTIN Special Drug Use Surveillance (Recurrent, or metastatic carcinoma of the cervix) |
Date of disclosure of the study information | 2016/06/01 |
Last modified on | 2019/03/29 17:58:23 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/05/20 14:59:51 | ||
2 | Update | 2016/05/20 16:30:09 | Classification by specialty |
|
3 | Update | 2016/05/20 16:31:02 | Gender |
|
4 | Update | 2016/05/20 17:50:21 | Narrative objectives1 Primary outcomes |
|
5 | Update | 2016/05/30 16:57:04 | Anticipated trial start date |
|
6 | Update | 2016/05/30 16:57:57 | Date of disclosure of the study information |
|
7 | Update | 2016/06/01 10:53:08 | Recruitment status |
|
8 | Update | 2017/06/02 04:34:47 | Recruitment status |
|
9 | Update | 2017/06/02 04:37:13 | Name of person sending information Name of person sending information |
|
10 | Update | 2017/06/05 13:22:30 | Division name Division name TEL Last name of contact person Last name of contact person Division name Division name TEL Division name Division name |
|
11 | Update | 2018/02/06 14:05:42 | Last name of lead principal investigator Last name of lead principal investigator TEL |
|
12 | Update | 2018/03/01 10:03:59 | Last name of lead principal investigator Last name of lead principal investigator TEL |
|
13 | Update | 2018/03/01 10:19:10 | Recruitment status |
|
14 | Update | 2019/03/29 17:58:23 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code TEL Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |